1. Home
  2. RYTM vs GEF Comparison

RYTM vs GEF Comparison

Compare RYTM & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • GEF
  • Stock Information
  • Founded
  • RYTM 2008
  • GEF 1877
  • Country
  • RYTM United States
  • GEF United States
  • Employees
  • RYTM N/A
  • GEF N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • GEF
  • Sector
  • RYTM Health Care
  • GEF
  • Exchange
  • RYTM Nasdaq
  • GEF Nasdaq
  • Market Cap
  • RYTM 3.8B
  • GEF 3.2B
  • IPO Year
  • RYTM 2017
  • GEF N/A
  • Fundamental
  • Price
  • RYTM $61.74
  • GEF $51.32
  • Analyst Decision
  • RYTM Strong Buy
  • GEF Buy
  • Analyst Count
  • RYTM 12
  • GEF 7
  • Target Price
  • RYTM $74.92
  • GEF $75.67
  • AVG Volume (30 Days)
  • RYTM 940.6K
  • GEF 174.2K
  • Earning Date
  • RYTM 05-06-2025
  • GEF 06-04-2025
  • Dividend Yield
  • RYTM N/A
  • GEF 4.21%
  • EPS Growth
  • RYTM N/A
  • GEF N/A
  • EPS
  • RYTM N/A
  • GEF 4.43
  • Revenue
  • RYTM $130,126,000.00
  • GEF $5,508,100,000.00
  • Revenue This Year
  • RYTM $43.84
  • GEF N/A
  • Revenue Next Year
  • RYTM $65.62
  • GEF $12.10
  • P/E Ratio
  • RYTM N/A
  • GEF $11.57
  • Revenue Growth
  • RYTM 68.06
  • GEF 6.88
  • 52 Week Low
  • RYTM $35.17
  • GEF $48.23
  • 52 Week High
  • RYTM $68.58
  • GEF $73.16
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 61.94
  • GEF 41.13
  • Support Level
  • RYTM $59.54
  • GEF $50.24
  • Resistance Level
  • RYTM $62.83
  • GEF $53.03
  • Average True Range (ATR)
  • RYTM 4.27
  • GEF 2.14
  • MACD
  • RYTM 1.00
  • GEF -0.02
  • Stochastic Oscillator
  • RYTM 92.04
  • GEF 41.31

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: